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Recent advances in high-throughput sequencing techno-
lo gies have greatly increased the scale and scope of 
genomics research, and this was evident throughout the 
recent Biology of Genomes meeting at the Cold Spring 
Harbor Laboratory. Here we describe some highlights of 
the meeting.
Functional and cancer genomics
In one of several talks that investigated the causes, 
dynamics and phenotypic effects of regulatory change, 
Mike Snyder (Stanford University, Stanford, USA) used 
chromatin immunoprecipitation followed by DNA 
sequencing (ChIP-seq) to examine the variability in 
transcription factor binding among individuals in yeast 
(Saccharomyces cerevisiae) and human. In both species, 
significant variation was observed, and the amount of 
binding was strongly correlated with gene expression. 
Much of the observed binding variation could be asso-
ciated with specific single nucleotide polymorphisms 
(SNPs) and structural changes to the genome. On the 
basis of the patterns of variation, Snyder suggested that 
gene regulation may work like a government, with global 
regulators and local regulators all having strong effects, 
but with some focused on a more limited set of loci.
Snyder’s talk introduced two themes that appeared 
throughout the meeting: the widespread adoption of 
high-throughput sequencing as an analysis strategy; and 
a focus on identifying and understanding regulatory 
elements. Axel Visel (Lawrence Berkeley National 
Labora tory, Berkeley, USA) continued these themes in a 
talk that highlighted the limitations of using comparative 
genomics to identify enhancers. By performing ChIP-seq 
with the enhancer-associated p300 protein on mouse 
forebrain and embryonic heart tissue, he and colleagues 
identified a large number of heart enhancers with very 
low evolutionary conservation compared to forebrain 
enhancers. This surprising result suggests that deep path-
way conservation does not imply regulatory sequence 
conservation, that enhancer conservation is not predic-
tive of function, and that there are global differences in 
enhancer conservation between tissues.
Li Ding (Washington University, St Louis, USA) 
described how sequencing samples from the same 
patients at different stages of the same cancer can help 
track changes that have occurred during cancer progres-
sion, and possibly lead to improved drug therapies. 
Thanks to an efficient pipeline, their genome-sequencing 
center can analyze tumor/pair samples in only 12 days. 
The analysis of about 150 cancer genomes using this 
pipeline has enabled comparisons of different cancer 
genomes from different points of view, including muta-
tion rate, mutation spectrum, copy number variation and 
structural variation. The results showed by Elaine Mardis 
(Washington University, St Louis, USA) are an example 
of how powerful these tools are and what they are able to 
achieve. She presented the analysis of the relapse genome 
of an acute myelogenous leukemia patient and a com-
pari son with the genome sequenced at initial presen-
tation. Interestingly, this study was able to pinpoint 
relapse-specific mutations most likely involved in disease 
progression.
Complex trait mapping
One of the largest open issues in human genetics deals 
with the question of ‘missing heritability’: given the 
generally high estimates of heritability for many complex 
traits (such as genetic susceptibility to complex diseases), 
why have genome-wide association studies (GWAS) 
identified variants that explain only a small fraction of 
the heritable variation we know is out there? Several talks 
explored this question using a range of experimental and 
theoretical approaches. One hypothesis suggests that 
rare variants of large effect, which will generally be 
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missed by GWAS, are a crucial component of this 
missing variability. Richard Durbin (Wellcome Trust 
Sanger Institute, Cambridge, UK) and others described 
progress on the 1000 Genomes Project, which by next 
year will generate low-coverage (around 4x) whole-
genome sequence data from more than 2,000 individuals. 
This dataset, in conjunction with new imputation algor-
ithms for base-calling low-coverage data, will provide a 
near-complete catalog of rarer variants (for example, 
minor allele frequency ≥0.005) across the human 
genome, which in turn will facilitate efforts to identify 
rare variants affecting disease susceptibility.
Jeffrey Barrett (Wellcome Trust Sanger Institute, 
Cambridge, UK) addressed the subject of ‘synthetic asso-
ciations’. It has been proposed that many GWAS hits are 
not the result of common variants of modest effect, but 
rather are artifacts caused by linkage to multiple rare (but 
highly penetrant) variants. Barrett’s talk outlined several 
compelling sources of evidence suggesting that these 
synthetic associations are likely to be quite rare. So, while 
rare variants may or may not explain the ‘missing 
heritability’ problem, they are not a probable cause of the 
associations already discovered by GWAS.
One alternative approach to understanding the genetic 
architecture of complex traits is to use a more tractable 
genetic system. Barak Cohen (Washington University, St 
Louis, USA) presented detailed genetic analyses of 
sporulation efficiency in the yeast S. cerevisiae. For this 
phenotype, just four SNPs (located in three transcription 
factor genes) combine to explain 87% of the total 
phenotypic variation, although very little of this (around 
25%) could be ascribed to additive effects. Cohen also 
described a thermodynamic model that might explain the 
strong interactions (epistasis) observed among SNPs. 
This and other work raises the possibility that gene-gene 
interactions may be a large part of the answer to the 
missing heritability question.
Evolutionary genomics
Next-generation sequencing technologies now enable 
researchers not affiliated with genome centers to conduct 
their own genome-sequencing projects. Peter Donnelly 
(Oxford University, UK) described some preliminary 
findings from the PanMap project, a collaborative effort 
to sequence and analyze the genomes of ten Western 
chimpanzees (Pan troglodytes verus). Donnelly and 
colleagues were especially interested in the evolution of 
recombination rates, and the recent fusion between 
chimpanzee chromosomes 2a and 2b can be used as a 
‘natural experiment’ to estimate if and how chromosome 
position influences recombination rate. The results 
suggest that recombination rates are more affected by 
chromosomal position than they are by local sequence 
context.
Another exciting genome project was described by 
Svante Pääbo (Max Planck Institute for Evolutionary 
Anthropology, Leipzig, Germany). As a follow-up to the 
recent publication of the Neanderthal genome, Pääbo 
and colleagues have now generated roughly 2x coverage 
of the whole genome from an unclassified hominin fossil 
found in Denisova Cave in southern Siberia. Preliminary 
results suggest that the Denisova fossil is more closely 
related to Neanderthals than to modern humans, though 
the divergence between Neanderthal and the Denisova 
fossil is larger than the divergence between any two 
extant modern humans. Further studies will be needed to 
clarify the precise evolutionary relationships between 
this fossil and other hominin groups.
New directions
Several talks gave exciting glimpses of how next-genera-
tion sequencing technology can enable novel, high-
throughput experimental analyses. Rob Mitra (Washing-
ton University School of Medicine, St Louis, USA) 
introduced a promising new technology for investigating 
the regulatory networks of development across a cell 
lineage. By attaching a transposase to a transcription 
factor, Mitra forces the insertion of a transposon ‘calling 
card’ near the site of DNA-binding events. These trans-
posons, and thus binding sites, can then be identified by 
next-generation sequencing. As these trans posons 
survive cell divisions, the binding history of a transcrip-
tion factor can be traced though a cell lineage. The 
method has been applied successfully in yeast and tests 
are in progress in vertebrates. If successful, this approach 
would yield a powerful tool for decoding how regulation 
drives tissue-specific development.
Although the meeting focused primarily on humans 
and model organisms, considerable attention was given 
to the large quantities of diverse data being generated by 
the sequencing of microbial communities through 
projects such as the Global Ocean Sampling Expedition 
and the Human Microbiome Project (HMP). Katherine 
Pollard (Gladstone Institutes, University of California, 
San Francisco, USA) argued that traditional approaches 
to genomic analysis must be significantly adapted to take 
advantage of the new kinds of information in meta-
genomic data, which is produced by shotgun sequencing 
the DNA extracted from environmental samples. She 
showed that phylogenies inferred from metagenomic 
sequence reads allow new ways of defining species, such 
as Operational Taxonomic Units (OTUs), of discovering 
novel OTUs, of defining and comparing microbial com-
mu nity diversity, and of estimating microbial ranges in 
geographic and niche spaces.
In regard to the human microbiome, Jennifer Wortman 
(University of Maryland School of Medicine, Baltimore, 
USA) emphasized the HMP’s goal of discovering 
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potential correlations between changes in microbial 
community composition and the health of the human 
host. Referencing studies of the vaginal and gut micro-
biomes, she showed that different types of communities 
require bioinformatic tools with different levels of 
resolution and specialization. By sequencing the com-
plete genomes of several closely related microbes 
collected from coastal ocean populations, B Jesse Shapiro 
(Massachusetts Institute of Technology, Cambridge, 
USA) took a step towards understanding microbial 
speciation with his presentation of a well-supported 
sympatric model of speciation in which populations are 
ecologically differentiated by a set of niche-specific genes.
Finally, James Taylor (Emory University, Atlanta, USA) 
offered an integrated vision of how we might aim to do 
science in the age of next-generation sequencing. He 
emphasized two fundamental directions: first, increasing 
access to the ability to perform large-scale computational 
analyses; and second, and perhaps more important, 
ensuring that such analyses are done in a way that 
supports and encourages the integrity of scientific 
investi gation. Taylor demonstrated by an analysis of a 
mitochondrial genome resequencing experiment that 
commercial cloud computing platforms can be used in 
conjunction with Galaxy, a web-based genome analysis 
tool, to facilitate large-scale analyses that potentially 
involve multiple software programs, while maintaining 
the transparent provenance of the data and parameters. 
The resulting record of every step of the workflow 
guarantees that an analysis is reproducible and can be 
clearly communicated. Taylor also noted that in order to 
completely guarantee reproducibility, the original data 
themselves must be stored permanently, which raises 
another challenge for this new scientific paradigm.
New experimental technologies are giving individual 
labs the opportunity to conduct large-scale genomic 
studies that were unimaginable just a few years ago. 
However, the data generated on this scale present new 
challenges in interpretation, analysis and data manage-
ment. Given the quality of the science presented at this 
meeting, we are confident that the community will find 
creative and collaborative solutions for these issues.
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